SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-048583
Filing Date
2024-04-26
Accepted
2024-04-25 20:00:48
Documents
11
Period of Report
2024-04-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K acor-20240425.htm   iXBRL 8-K 36836
  Complete submission text file 0000950170-24-048583.txt   149889

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acor-20240425.xsd EX-101.SCH 24851
15 EXTRACTED XBRL INSTANCE DOCUMENT acor-20240425_htm.xml XML 4710
Mailing Address TWO BLUE HILL PLAZA PEARL RIVER NY 10965
Business Address TWO BLUE HILL PLAZA PEARL RIVER NY 10965 914-347-4300
Acorda Therapeutics, Inc. (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 133831168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 24878247
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)